Viral hepatitis: Scaling up HCV treatment in resource-limited countries

Nature Reviews Gastroenterology and Hepatology

Volumn 12, Issue 4, 2015, Pages 193-194

  Lemoine, Maud ^a   Thursz, Mark ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; ANTIVIRUS AGENT;

COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; HEALTH CARE ACCESS; HEALTH CARE COST; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SCALE UP; SHORT SURVEY; TREATMENT DURATION; VIRUS TRANSMISSION; DEVELOPING COUNTRY; THEORETICAL MODEL;

ANTIVIRAL AGENTS; DEVELOPING COUNTRIES; HEPATITIS C; HUMANS; MODELS, THEORETICAL;

EID: 84926416163     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2015.31     Document Type: Short Survey

References (10)

1. Mohd Hanafiah K., Groeger J., Flaxman A. D. & Wiersma S. T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57, 1333-1342 (2013
2. Perz J. F., Armstrong G. L., Farrington L. A., Hutin Y. J. & Bell B. P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45, 529-538 (2006
3. Davis G. L., Alter M. J., El-Serag H., Poynard T. & Jennings L. W. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138, 513-521 (2010
4. Obach D., et al. How to optimize HCV treatment impact on life years saved in resource-constrained countries. Hepatology http://dx.doi.org/10.1002/hep.27691
5. Hill A., Khoo S., Fortunak J., Simmons B. & Ford N. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin. Infect. Dis. 58, 928-936 (2014
6. Lemoine M. & Thursz M. Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas. Semin. Liver Dis. 34, 89-97 (2014
7. Lemoine M., Eholie S. & Lacombe K. Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach. J. Hepatol. 62, 469-476 (2015
8. WHO. Guidelines for the screening care and treatment of persons with hepatitis C infection. WHO [online] http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/(2014
9. El-Zanaty F. & Way A. Egypt: Demographic and Health Survey 2008. Demographic and Healthy Surveys [online], http://dhsprogram.com/pubs/pdf/fr220/fr220.pdf (2008
10. Thomas D. L. Cure of hepatitis C virus infection without interferon alfa: scientific basis and current clinical evidence. Top. Antivir. Med. 21, 152-156 (2014